UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone loss caused by iron overload in a murine model: importance of oxidative stress

Blood, 2010-10, Vol.116 (14), p.2582-2589

2010

Volltextzugriff (PDF)

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

PloS one, 2012-03, Vol.7 (3), p.e32345-e32345

2012

Volltextzugriff (PDF)

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Nature medicine, 2013-04, Vol.19 (4), p.437-445

2013

Volltextzugriff (PDF)

An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres

British journal of haematology, 2022-01, Vol.196 (2), p.380-389

2022

Volltextzugriff (PDF)

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

The Journal of clinical investigation, 2010-12, Vol.120 (12), p.4466-4477

2010

Volltextzugriff (PDF)

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Journal of bone and mineral research, 2009-03, Vol.24 (3), p.543-557

2009

Volltextzugriff (PDF)

Combined iron chelation therapy

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.79-86

2010

Volltextzugriff (PDF)

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea

PloS one, 2013-02, Vol.8 (2), p.e55709-e55709

2013

Volltextzugriff (PDF)

Epidemiologic and clinical characteristics of nontransfusion‐dependent thalassemia in the United States

Pediatric blood & cancer, 2018-07, Vol.65 (7), p.e27067-n/a

2018

Volltextzugriff (PDF)

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Haematologica (Roma), 2013-01, Vol.98 (1), p.129-135

2013

Volltextzugriff (PDF)

Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major

Pediatric blood & cancer, 2015-07, Vol.62 (7), p.1303-1304

2015

Volltextzugriff (PDF)

Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease

Pediatric blood & cancer, 2013-04, Vol.60 (4), p.653-658

2013

Volltextzugriff (PDF)

The palatability and tolerability of deferasirox taken with different beverages or foods

Pediatric blood & cancer, 2013-09, Vol.60 (9), p.1507-1512

2013

Volltextzugriff (PDF)

Safety and pharmacokinetics of the oral iron chelator SP-420 in [beta]-thalassemia

American journal of hematology, 2017-12, Vol.92 (12), p.1356

2017

Volltextzugriff (PDF)

Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia

American journal of hematology, 2017-12, Vol.92 (12), p.1356-1361

2017

Volltextzugriff (PDF)

Chelation therapy in β-thalassemia: An optimistic update

Seminars in hematology, 2001-10, Vol.38 (4), p.360-366

2001

Volltextzugriff (PDF)

A preclinical approach for gene therapy of β-thalassemia

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.134-140

2010

Volltextzugriff (PDF)

Pregnancy outcomes in women with thalassemia in North America and the United Kingdom

American journal of hematology, 2013-09, Vol.88 (9), p.771-773

2013

Volltextzugriff (PDF)

Hepcidin and Hfe in iron overload in β-thalassemia

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.221-225

2010

Volltextzugriff (PDF)

Low Bone Mineral Density in Adolescents with β-Thalassemia

Annals of the New York Academy of Sciences, 2005-11, Vol.1054 (1), p.462-466

2005

Volltextzugriff (PDF)

Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2 in patients with thalassemia major on various chelation regimens: A 6‐year study

American journal of hematology, 2013-08, Vol.88 (8), p.652-656

2013

Volltextzugriff (PDF)

Changes in Bone Microarchitecture and Biomechanical Properties in the th3 Thalassemia Mouse are Associated with Decreased Bone Turnover and Occur During the Period of Bone Accrual

Calcified tissue international, 2010-06, Vol.86 (6), p.484-494

2010

Volltextzugriff (PDF)

Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

Haematologica (Roma), 2008-08, Vol.93 (8), p.1247

2008

Volltextzugriff (PDF)

1 – 25 von 187

Suche als RSS-Feed

Aktive Filter

ThemaAnemias. Hemoglobinopathies

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bone loss caused by iron overload in a murine model: importance of oxidative stress

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)

A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Combined iron chelation therapy

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea

Epidemiologic and clinical characteristics of nontransfusion‐dependent thalassemia in the United States

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major

Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease

The palatability and tolerability of deferasirox taken with different beverages or foods

Safety and pharmacokinetics of the oral iron chelator SP-420 in [beta]-thalassemia

Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia

Chelation therapy in β-thalassemia: An optimistic update

A preclinical approach for gene therapy of β-thalassemia

Pregnancy outcomes in women with thalassemia in North America and the United Kingdom

Hepcidin and Hfe in iron overload in β-thalassemia

Low Bone Mineral Density in Adolescents with β-Thalassemia

Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2 in patients with thalassemia major on various chelation regimens: A 6‐year study

Changes in Bone Microarchitecture and Biomechanical Properties in the th3 Thalassemia Mouse are Associated with Decreased Bone Turnover and Occur During the Period of Bone Accrual

Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

Aktive Filter

Suchergebnisse filtern